This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Indranil Mitra: Innovator in Glycated Hemoglobin Measurement
Introduction
Indranil Mitra is a notable inventor based in München Süd, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the measurement of glycated hemoglobin.
Latest Patents
Mitra holds a patent for a method titled "Method for Determining Glycated Hemoglobin A (HbA1c) by Mass Spectrometry." This innovative approach enhances the accuracy and efficiency of HbA1c testing, which is crucial for diabetes management. He has 1 patent to his name.
Career Highlights
Throughout his career, Indranil Mitra has worked with prominent companies in the healthcare sector. He has been associated with Roche Diagnostics GmbH and F. Hoffmann-La Roche AG, where he contributed to advancements in diagnostic technologies.
Collaborations
Mitra has collaborated with esteemed professionals in his field, including Uwe Kobold and Andreas Leinenbach. Their collective expertise has furthered the development of innovative diagnostic solutions.
Conclusion
Indranil Mitra's work in the field of glycated hemoglobin measurement exemplifies the impact of innovation in medical diagnostics. His contributions continue to influence diabetes care and management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile